DAVID EDALATI: Open Payments
NPI 1477669141 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,824 in 158 payments from 37 companies in 2025. Trend: 2023 $3,784 · 2024 $3,475 · 2025 $3,824
Food & beverage: $3,807Education: $17
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $436 |
| Novo Nordisk Inc | 8 | $344 |
| AstraZeneca Pharmaceuticals LP | 11 | $322 |
| ABBVIE INC. | 16 | $309 |
| GlaxoSmithKline, LLC. | 11 | $265 |
| Lilly USA, LLC | 11 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $183 |
| Otsuka America Pharmaceutical, Inc. | 7 | $176 |
| Abbott Laboratories | 3 | $153 |
| SHIELD THERAPEUTICS INC | 2 | $132 |
Products named: Auvelity, Wegovy, CAPLYTA, REXULTI, MOUNJARO, Symbravo, FREESTYLE LIBRE 3, TRELEGY ELLIPTA.
Industry payments across KS — which companies pay providers there.
